Celltrion’s influenza antibody patented in Australia, Japan
Aug 29, 2016
[ THE INVESTOR ] South Korean biotechnology firm Celltrion announced on Aug. 29 that it has obtained patents regarding CT-P23 antibody specific to influenza A virus in Australia and Japan. Accor...